If the AI biotech bubble were to burst, we might see a significant number of AI-focused companies either go bankrupt or be ...

Microbiotica’s microbiome drugs MB310 and MB097 have been approved for phase 1b studies to enhance ICI efficacy.

How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question.

Discover how Cryoport Systems can help you navigate EMEA regulations and manage the supply chain complexities for advanced ...

As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the ...

First explained in 1978, antisense oligonucleotides are short, single-stranded synthetic fragments of DNA or RNA that bind ...

Aelix Therapeutics is a clinical-stage biotech company based in Barcelona, in the northeast of Spain. It is a spin-off of HIVACAT – a Catalan program for the development of therapeutic vaccines and ...